阅读说明：本技术 用抗pd-1抗体***的方法 (Method of treating tumors with anti-PD-1 antibodies ) 是由 R·爱德华兹 W·J·格泽 D·M·格里纳沃尔特 于 2018-06-01 设计创作，主要内容包括：本公开提供用于治疗患有肿瘤的受试者的方法,该方法包括对受试者施用特异性结合程序性死亡-1(PD-1)受体并抑制PD-1活性的抗体或其抗原结合部分。在一些实施方案中,该肿瘤源自非小细胞肺癌(NSCLC)。在一些实施方案中,该肿瘤表达程序性死亡配体1。在一些实施方案中,该受试者携带野生型STK11基因。(The present disclosure provides methods for treating a subject having a tumor, the method comprising administering to the subject an antibody, or antigen-binding portion thereof, that specifically binds to a programmed death-1 (PD-1) receptor and inhibits PD-1 activity. In some embodiments, the tumor is derived from non-small cell lung cancer (NSCLC). In some embodiments, the tumor expresses programmed death ligand 1. In some embodiments, the subject carries a wild-type STK11 gene.)